ArticleVaccines2026
Acceptability of HPV Vaccination for Daughters: A University Hospital-Wide Questionnaire Survey.
Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
BACKGROUND/
objectivesJapan has experienced a marked decline in human papillomavirus (HPV) vaccination coverage, reaching less than 1%, after the government suspended its proactive recommendation in 2013, following media reports of symptoms alleged to be adverse events caused by the vaccine. Although the recommendation was reinstated in 2022 after comprehensive safety reviews, vaccination rates have remained modest. We aimed to assess HPV vaccine acceptability and identify factors associated with acceptance among staff at a university hospital.
methodsWe administered a web-based questionnaire in February 2024 to 2761 hospital employees, assessing demographic and professional characteristics, HPV-related knowledge, awareness about vaccine effectiveness, adverse events, and catch-up programs, as well as acceptability across four hypothetical scenarios reflecting publicly funded and self-funded vaccination programs. Logistic regression analyses were conducted to identify factors associated with acceptability.
resultsAmong 1132 respondents (response rate 41.0%), acceptability exceeded 75% in the publicly funded scenarios but was approximately 45% in the self-funded scenarios. In multivariable analyses of the publicly funded scenarios, younger age, being a medical professional, greater HPV vaccine knowledge levels, and awareness about HPV vaccine effectiveness or catch-up vaccination were positively associated with acceptability; awareness about adverse events showed negative associations. In the self-funded scenarios, women were less likely to accept vaccination, but greater knowledge levels and awareness of catch-up vaccination remained positively associated with acceptability.
conclusionsThese findings suggest that strategies tailored to specific population characteristics are important for improving HPV vaccine acceptability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.